June 7, 2017June 7, 2017
Patient Shows Raynaud’s Phenomenon Symptoms in Her Tongue
News
Doctors believe a 29–year–old woman had Raynaud’s phenomenon in her tongue, a study reported. The patient had a six–month history ... Read more
May 31, 2017May 31, 2017
Phase 3 STAR Trial of Cytori’s Cell Therapy Completes 48-Week Follow-up Visits
News
The Phase 3 STAR trial investigating the safety and effectiveness of a cell therapy based on adipose-derived regenerative cells (ADRCs) ... Read more
May 17, 2017May 17, 2017
New Approach Overcomes Obstacles to Model Vibration-Triggered Raynaud’s
News
An advanced theoretical model of vibration-induced Raynaud’s phenomenon suggests that vibrations cause capillary walls in the hand to thicken, ... Read more
May 10, 2017
Raynaud’s Appears as First Sign of Recurrence of Rare PGL Tumor: a Case Report
News
A 17-year-old girl presented Raynaud’s penomenon symptoms as a clinical signal of the recurrence of paraganglioma (PGL), a very ... Read more
May 3, 2017May 3, 2017
Early Damage to Endothelial Cells in Raynaud’s May Be Linked to Systemic Sclerosis Development
News
Patients with Raynaud’s phenomenon show high levels of damage to the cells lining the interior of blood vessels — the ... Read more
April 26, 2017April 26, 2017
Botulinum Toxin Has Variable Effectiveness in Patients with Scleroderma-associated Raynaud’s
News
Botulinum Toxin Type A (Btx-A) treatment for Raynaud’s phenomenon (RP) may not be effective for all patients diagnosed with scleroderma, according ... Read more
April 20, 2017April 20, 2017
Review Discusses Use of Infrared Thermal Imaging to Diagnose Raynaud’s
News
A recent review discussed the current and possible future applications of infrared thermal imaging (IRT) to diagnose Raynaud’s phenomenon. ... Read more
April 10, 2017April 10, 2017
Apricus Advancing RayVa to Phase 2b Trial for Raynaud’s Treatment
News
Apricus Biosciences plans to initiate a Phase 2b study evaluating RayVa (alprostadil), the company’s investigative treatment for Raynaud’s phenomenon. In a press ... Read more
April 6, 2017April 6, 2017
New Noninvasive Test Assesses Peripheral Circulatory Function in Women with Raynaud’s
News
A study from Japan outlines a new rapid and noninvasive approach to detect and monitor peripheral circulatory problems in ... Read more
March 22, 2017March 22, 2017
Tracleer, Ventavis Combo May Improve Hand Blood Vessels in Scleroderma with Raynaud’s
News
Tracleer (bosentan) combined with Ventavis (iloprost) reduced abnormalities in the tiny blood vessels in the hands of patients with ... Read more
March 15, 2017March 15, 2017
Abnormal Red Blood Cells Detected in Raynaud’s Patients May Contribute to Disease, Study Suggests
News
Patients with Raynaud’s syndrome may present problems in their red blood cells, particularly increased cell aggregation and impaired deformability, ... Read more
March 9, 2017March 9, 2017
Minor Hand Injury Led to Raynaud’s Phenomenon and Lupus Diagnosis
News
A recent case report published in The Journal of Emergency Medicine highlights a case of Raynaud’s phenomenon associated with ... Read more

March 1, 2017March 1, 2017

Raynaud’s May Be Linked to Formation of Finger Pad Tophi, Case Study Suggests

News

Raynaud’s phenomenon may be linked to the formation of tophi, or deposits of uric acid crystals, in the finger pads, suggests a case study published in the Journal of ... Read more

February 15, 2017February 15, 2017

Estrogen Likely Contributes to Cold-induced Raynaud’s in Women

News

Estrogen may contribute to the development of Raynaud’s phenomenon in women, according to a study examining the relationship between palm blood flow and the hormone in mice. The findings ... Read more

February 8, 2017February 8, 2017

FDA Grants Cytori Therapeutics Small Business Status in the US

News

The U.S. Food and Drug Administration (FDA) has granted Cytori Therapeutics Small Business status designation for fiscal year 2017, meaning that the company will pay reduced fees for regulatory filings that ... Read more

February 1, 2017February 1, 2017

Raynaud’s Case Report Highlights Need for Cautious Glucose Monitoring to Avoid Overtreatment

News

Recognizing the signs and early identification of artifactual hypoglycemia in patients with Raynaud’s phenomenon and/or systemic sclerosis is critical to prevent overtreatment, according to researchers. The study, “Artifactual Hypoglycaemia ... Read more

January 25, 2017January 25, 2017

Case Report Documents Severe Secondary Raynaud’s in Black-African Woman

News

A case report of severe Raynaud’s phenomenon in a black-African woman illustrates the difficulties clinicians still face for diagnosis and management. The report, “Difficulties in diagnosis and treatment of ... Read more

January 18, 2017January 18, 2017

In Rare Case, Raynauld’s Symptoms Stopped by Treating Underlying Blood Disorder

News

Raynaud’s symptoms ceased in a woman after treatment with hydroxycarbamide returned her platelet count to normal, according to a case study published in the journal of Case Reports in Medicine. The ... Read more

January 11, 2017January 11, 2017

Cytori to Include Raynaud’s Phenomenon in Its Scleroderma Cell Therapy Program

News

Cytori Therapeutics will expand the development of its ECCS-50 scleroderma treatment to include secondary Raynaud’s phenomenon (RP), under the brand Habeo Cell Therapy. Habeo means “to hold” in Latin and ... Read more

January 4, 2017January 4, 2017

Clinical Trial Finds No Evidence that Acupressure is Effective for Treating Raynaud’s

News

A randomized, controlled clinical trial was performed to evaluate the effects of acupressure on Raynaud’s phenomenon (RP), however, no significant impact on RP symptoms was observed. The results of ... Read more

December 29, 2016December 29, 2016

Raynaud’s Phenomenon Most Common Symptom Signaling Mixed Connective Tissue Disease

News

Raynaud’s phenomenon may signal the development of mixed connective tissue disease, as a study showed that it was the most common symptom in people who were later diagnosed with ... Read more

December 7, 2016December 7, 2016

Revlimid May Effectively Treat Raynaud’s Phenomenon in Pediatric SLE, Study Shows

News

Revlimid (lenalidomide) was found to effectively treat skin manifestations in adolescents with systemic lupus erythematosus, including Raynaud’s phenomenon. The study, “Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus ... Read more

December 2, 2016December 2, 2016

Study Finds Reduced Blood Flow in Heart Tissue of Raynaud’s Patients

News

Patients with both primary and secondary Raynaud’s phenomenon have an abnormally low blood penetration in the heart tissue, which likely explains the increased death rates from heart disease in ... Read more

November 30, 2016November 30, 2016

Extension Study Gets Underway for Resunab as Treatment for Dermatomyositis Patients

News

Corbus Pharmaceuticals is starting a one-year, open-label extension study for the ongoing Phase 2 clinical trial evaluating the effect of Resunab in patients with skin-predominant dermatomyositis – an inflammatory disease ... Read more

Patient Shows Raynaud’s Phenomenon Symptoms in Her Tongue

Phase 3 STAR Trial of Cytori’s Cell Therapy Completes 48-Week Follow-up Visits

New Approach Overcomes Obstacles to Model Vibration-Triggered Raynaud’s

Raynaud’s Appears as First Sign of Recurrence of Rare PGL Tumor: a Case Report

Early Damage to Endothelial Cells in Raynaud’s May Be Linked to Systemic Sclerosis Development

Botulinum Toxin Has Variable Effectiveness in Patients with Scleroderma-associated Raynaud’s

Review Discusses Use of Infrared Thermal Imaging to Diagnose Raynaud’s

Apricus Advancing RayVa to Phase 2b Trial for Raynaud’s Treatment

New Noninvasive Test Assesses Peripheral Circulatory Function in Women with Raynaud’s

Tracleer, Ventavis Combo May Improve Hand Blood Vessels in Scleroderma with Raynaud’s

Abnormal Red Blood Cells Detected in Raynaud’s Patients May Contribute to Disease, Study Suggests

Minor Hand Injury Led to Raynaud’s Phenomenon and Lupus Diagnosis